Navigation Links
Aspreva Announces Preliminary Revenues for Third Quarter 2007
Date:10/16/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... Gilbert Hospital, known...has initiated a new customer service campaign enti...ice; Mission; Ideals; Leadership; Excellence was d...ie of Inpatient Services and Carolyn Masood of Per...f the S.M.I.L.E. campaign came to life in order to...
(Date:11/21/2008)...ng pregnancy needed less pain meds, study found ,...ing aquarobics during pregnancy reduces the amount...ing labor, according to a Brazilian study that inc...ere assigned to attend three 50-minute sessions a ...he other half acted as a control group. , "We f...
(Date:11/21/2008)... The U.S. Department of ...for Patient Safety Organizations (PSOs). , ,... provides final requirements and procedures for PS... care providers can work to collect, aggregate and...t of privilege and confidentiality protections - t...
(Date:11/21/2008)...21 Just three days after the,JUPI...eart Association meeting,and simultaneously publi..., an,AlphaDetail survey of more than 100 primary ...a 14% increase in the use of drug therapy among th...or low to moderate risk patients. , The JUP...
Breaking Medicine News(10 mins):Health News:Gilbert Hospital Kicks Off New Customer Service S.M.I.L.E. Campaign 2Health News:Aquarobics May Help Ease Labor 2Health News:Final Rule Issued for Patient Safety Organizations 2Health News:Final Rule Issued for Patient Safety Organizations 3Health News:Physicians Anticipate Higher Prescribing Based on JUPITER Study 2
...s human papillomavirus vaccine Gardasil is effecti...ing to a study to be published on Saturday in the...linical trials has been shown to be 100% effective...ns 16 and 18, which together cause about 70% of ce...
...n of the world's largest cities have agreed on a $...buildings in their cities to save energy , in the ...ormer US president Bill Clinton launched the initi...ummit in New York attended by mayors and governors...
...study has found that children with both autism and...imes more likely to bully than children in the ge...ning against labelling kids with autism and ADHD a...l that they may only be trying to let out pent up ...
...ists have developed a new electro-chemical biosens...ts of atrazine, one of the most widely used herbi...lasting effects on the environment as well as anti...aster, more portable and economic than the expensi...
Other Medicine News:Health News:World Cities Join Hands to Combat Climate Change 2Health News:Kids With Both Autism and ADHD Four Times More Likely to Bully 2Health News:New Electro-chemical Biosensor to Check Food Contamination 2
(Date:11/21/2008)...lif., Nov. 21 Amgen,(Na...ommittee for Medicinal,Products for Human Use (CH...rketing authorisation for Nplate(TM) (romiplostim)... Nplate for adult chronic immune (idiopathic),thr...s who are refractory to,other treatments (e.g. co...
(Date:11/21/2008)...nd, November 21 , ...mmittee for Medicinal Products for Human Use (CHMP... the approval of Enbrel(R),(etanercept) as a trea...escents with severe plaque psoriasis. If approved ...ee,s recommendation, Enbrel will become the,first...
(Date:11/21/2008)...v. 21 Ikaria Holdings, Inc. today ...f the Year by the New Jersey Technology Council (N...provides business support, networking opportunitie...es and their leaders. Ikaria earned the award base...ue product/service provision. , , "We are d...
(Date:11/20/2008)...., Nov. 20 Epeius Biotechnologies,...studies of Rexin-G in,chemotherapy-resistant meta...resented by Dr. Sant P. Chawla, principal investig...ndon UK on November 13-15, 2008. Patients received... up to 9 months. Analysis of,safety and efficacy ...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2Heritage Victor Valley Medical Group Celebrates Earth Day 17038 1Danong Chen appointed CEO of Theranostics Health 4657 1Danong Chen appointed CEO of Theranostics Health 4657 2U of M researchers identify process that may help treat Parkinsons spinal cord injuries 17034 1U of M researchers identify process that may help treat Parkinsons spinal cord injuries 17034 2More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 17030 1More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 17030 2
...--(BUSINESS WIRE)--Jun 1, 2007 - OXiGENE, Inc.,(NA...aceutical,company developing novel therapeutics to...e publication of two abstracts in the,2007 Annual ...Annual Meeting of the American Society of Clinical...ct reports for the first time full data from a,ran...
...nted at Annual Meeting of the American Society of,..., 2007 -- SciClone Pharmaceuticals,Inc. (Nasdaq:S...lone,s lead product candidate thymalfasin (ZADAXIN...nt in a phase 2 clinical trial,treating patients d...t advanced form of skin cancer. Results showed tha...
Other Medicine Technology:OXiGENE Abstracts Published in ASCO Program 2OXiGENE Abstracts Published in ASCO Program 3OXiGENE Abstracts Published in ASCO Program 4
0.12 mm. 1 x 2 teeth. Serrated handle with polished finish. Manufactured in titanium.
0.4 mm, 1 x 2 teeth 7 mm tying platform. Serrated handle with polished finish.
Also referred to as McLean-Putney suture forceps. Slightly curved 6 mm long platform. Serrated handle with polished finish. Most popular size or model.
Oval solid 16 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Cross action serrated handle with polished finish.
Medicine Products: